MangoRx Review 2026: The Public-Company Men's Health Platform
Back to Articles
Guides7 min readJuly 25, 2026

MangoRx Review 2026: The Public-Company Men's Health Platform

MangoRx's ED, hair, and TRT telehealth reviewed—the rare public-company transparency, the nearly empty customer record, and what to confirm before ordering.

By Med Consumer Watch Team
MangoRx (mangorx.com) is the men's telehealth platform of Mangoceuticals, Inc.—a Dallas-based company founded in 2021 that trades on NASDAQ under MGRX, an unusual credential in a category dominated by anonymous LLCs. Its lineup covers ED (the flagship "Mango" oral dissolvable), hair loss ("Grow"), and testosterone support ("Mojo" and "Prime"), serving 42 states. We researched it on July 25, 2026. This review contains affiliate links; the assessment is our own.

What MangoRx Sells

The product families, all prescription-based after an online visit:
  • Mango (ED) — a compounded oral-dissolvable combining PDE5 inhibitor(s) with oxytocin; branded generics also flow through the platform
  • Grow (hair loss) — a compounded dissolvable combining minoxidil and finasteride
  • Mojo / Prime (testosterone support) — enclomiphene-based and related protocols
  • Pricing is product-page and funnel-based—confirm your exact monthly cost at checkout

The compounded combinations are not FDA-approved products: PDE5-plus-oxytocin blends carry the same caveats as every combined ED formula we've reviewed (oxytocin's sexual-function evidence is thin), and PDE5 inhibitors are dangerous with nitrates. Finasteride carries sexual side-effect and pregnancy-exposure warnings. Single-agent FDA-approved generics remain the evidence-backed default—ask the prescriber why a combination fits your case.

The Public-Company Angle

Mangoceuticals' NASDAQ listing means audited financials, SEC filings, and a level of corporate accountability that anonymous telehealth LLCs can't match—you can literally read its risk factors. The flip side: its customer-review record is nearly empty. The main Trustpilot profile is unclaimed with essentially no reviews (a Canadian mirror shows 3.9 stars from 8), there's no BBB registration, and no complaint record could be verified—which cuts both ways: nothing bad on file, and nothing good at scale either. For a company founded in 2021, that thin footprint suggests modest customer volume relative to its visibility.

Availability and Practical Checks

MangoRx serves 42 states; program terms as of July 2026 exclude twelve—Alabama, Alaska, Arkansas, California, Kentucky, Louisiana, Michigan, Mississippi, North Dakota, South Carolina, South Dakota, and Wyoming—notably including California. Before ordering: confirm your monthly price and renewal terms in writing, ask which pharmacy compounds your product, verify the prescribing clinician's license, and check the refund policy for compounded prescriptions (typically non-returnable once shipped).

Common Questions

Quick answers to what buyers actually search:
  • Is MangoRx legit? — Yes, structurally: a NASDAQ-listed parent (MGRX) with SEC-filed transparency and licensed-clinician prescribing. Its customer-review record is nearly empty, so service quality is largely unproven in public.
  • What's in Mango ED? — A compounded oral-dissolvable combining PDE5 inhibition with oxytocin—not an FDA-approved combination; get exact ingredients and doses in writing.
  • How much does MangoRx cost? — Pricing is funnel-based by product; confirm your monthly total and renewal terms at checkout.
  • Where isn't MangoRx available? — Twelve states as of July 2026, including California.
  • MangoRx vs alternatives? — For plain ED generics, mainstream telehealth beats it on price and evidence; its dissolvable combinations compete with Rugiet and BraveRX, which have larger review records.

The Bottom Line

Verdict: 7.1/10—the category's most corporately transparent operator with its least-proven customer record. The NASDAQ listing earns real trust on the existential questions; the near-absence of reviews leaves service quality yours to discover, and the compounded combinations carry the usual evidence caveats against cheaper single-agent generics. If you try it: confirm pricing and renewal terms in writing, identify the pharmacy, and disclose all medications—especially nitrates—at intake. This review is informational only, not medical advice. Checked July 25, 2026; prices and terms change.

Sources & References

  • MangoRx — Official Site
  • Mangoceuticals, Inc. — Investor Relations (NASDAQ: MGRX)
  • ConsumersAdvocate — MangoRx ED and hair reviews
  • FDA — Compounding Information

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.